HilleVax, Inc.
HLVX
$1.86
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -11.74% | 7.97% | 18.66% | 30.72% | 47.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -42.32% | -19.79% | 16.98% | 43.21% | 67.79% |
| Operating Income | 42.32% | 19.79% | -16.98% | -43.21% | -67.79% |
| Income Before Tax | 25.79% | -19.18% | -39.41% | -68.43% | -20.79% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 25.79% | -19.18% | -39.41% | -68.43% | -20.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.79% | -19.18% | -39.41% | -68.43% | -20.79% |
| EBIT | 42.32% | 19.79% | -16.98% | -43.21% | -67.79% |
| EBITDA | 42.98% | 20.67% | -15.85% | -41.67% | -66.18% |
| EPS Basic | 13.76% | -21.25% | -9.44% | -37.51% | 12.42% |
| Normalized Basic EPS | 45.61% | 28.60% | 5.00% | -20.93% | 19.53% |
| EPS Diluted | 13.68% | -21.29% | -9.36% | -37.37% | 12.30% |
| Normalized Diluted EPS | 45.61% | 28.60% | 5.00% | -20.93% | 19.53% |
| Average Basic Shares Outstanding | 14.52% | 21.14% | 27.76% | 22.35% | 24.34% |
| Average Diluted Shares Outstanding | 14.52% | 21.14% | 27.76% | 22.35% | 24.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |